Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease-Reference-Cited by-同舟云学术

Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease

Published:2021-11 Issue: Volume:107 Page:57-69
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Lemercier Pablo^ORCID,Vergallo Andrea^ORCID,Lista Simone^ORCID,Zetterberg Henrik^ORCID,Blennow Kaj,Potier Marie-Claude^ORCID,Habert Marie-Odile^ORCID,Lejeune François-Xavier^ORCID,Dubois Bruno,Teipel Stefan,Hampel Harald

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference83 articles.

1. Abdi, H., Williams, L.J., 2013. Partial least squares methods: partial least squares correlation and partial least square regression. 549–579. doi:10.1007/978-1-62703-059-5_23

2. Resting state fMRI in Alzheimer's disease: beyond the default mode network;Agosta;Neurobiol. Aging,2012

3. Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort;Aguilar;Front. Aging Neurosci.,2014

4. On the path to 2025: understanding the Alzheimer's disease continuum;Aisen;Alzheimers. Res. Ther.,2017

5. Disruption of large-scale brain systems in advanced aging;Andrews-Hanna;Neuron,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma amyloid beta X‐42/X‐40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease;Alzheimer's & Dementia;2024-06-28

2. Analysis of complement system and its related factors in Alzheimer’s disease;BMC Neurology;2023-12-19

3. Application of unsupervised and supervised learning to a material attribute database of tablets produced at two different granulation scales;International Journal of Pharmaceutics;2023-06

4. A Review of Application of Aβ42/40 Ratio in Diagnosis and Prognosis of Alzheimer’s Disease;Journal of Alzheimer's Disease;2022-11-08

5. Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD;Frontiers in Drug Discovery;2022-08-24